基于微生物组的疗法的监管框架:对欧洲监管发展的见解
Julie Rodriguez1, Magali Cordaillat-Simmons2, Bruno Pot2,3
1Pharmabiotic Research Institute (PRI), Narbonne, France. julie@pharmabiotic.org.
NPJ biofilms and microbiomes
|March 29, 2025
概括
创新的微生物组疗法正在出现,促使欧洲法规的更新. 一个新的框架,即人类原产物质法规 (SoHO),对这些疗法产生影响,强调需要专门的微生物组调控科学.
科学领域:
- 微生物组研究的研究.
- 监管科学是一种监管科学.
- 欧盟政策 欧盟政策
背景情况:
- 基于微生物组的治疗方法的开发正在迅速推进.
- 现有的监管框架需要调整以适应这些新的治疗方法.
- 欧洲的监管格局正在随着治疗创新而演变.
研究的目的:
- 审查基于微生物组的创新疗法.
- 提供当前欧洲监管框架的概述.
- 分析"人类起源物质法规" (SoHO) 对微生物组治疗发展的影响.
主要方法:
- 关于微生物组疗法的文献综述.
- 分析欧洲监管文件,特别是SoHO法规.
- 综合监管变化及其影响.
主要成果:
- 一种广泛的微生物组疗法正在出现.
- 关于人类起源物质 (SoHO) 的条例引入了重大变化.
- 当前的法规对微生物组治疗的发展提出了挑战.
结论:
- 微生物组调节科学对于实现这些疗法的潜力至关重要.
- 调整监管框架是必要的,以支持创新.
- "SoHO法规"要求对微生物组疗法采取专注的方法.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
710
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
710
Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Introduction to the Human Microbiota
226
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
226
Development of Human Microbiota
73
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
73
The Oral Microbiota
98
The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
98
Human Virome
55
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
55


